| Eton Home Healthcare, Inc | |
| 4706 West Urbana Street, Broken Arrow, Oklahoma 74012 | |
| (918) 459-9645 | |
| Name | Eton Home Healthcare, Inc |
|---|---|
| Location | 4706 West Urbana Street, Broken Arrow, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377728 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 74008, 74011, 74012, 74014, 74015, 74017, 74021, 74037, 74047, 74063, 74066, 74070, 74073, 74103, 74104, 74105, 74106, 74107, 74108, 74110, 74112, 74114, 74115, 74126, 74127, 74128, 74129, 74132, 74133, 74134, 74135, 74136, 74137, 74145, 74146, 74361, 74365, 74447, 74467 |
| NPI Number | 1952470551 |
| Organization Name | ETON HOME HEALTHCARE, INC. |
| Address | 4706 W Urbana St, Broken Arrow, OK 74012 |
| Phone Number | 918-459-9645 |
News Archive
TeraRecon, Inc. (www.terarecon.com), global leader in advanced visualization and decision support solutions for medical imaging, is highlighting the selection and deployment of its iNtuition™ advanced visualization software by many of North America's largest healthcare enterprises, innovative physician practices and renowned luminary institutions at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago IL.
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
› Verified 6 days ago
| Quality Rating: |
News Archive
TeraRecon, Inc. (www.terarecon.com), global leader in advanced visualization and decision support solutions for medical imaging, is highlighting the selection and deployment of its iNtuition™ advanced visualization software by many of North America's largest healthcare enterprises, innovative physician practices and renowned luminary institutions at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago IL.
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 90.5 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.2 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.1 | 99.6 |
| How often the home health team checked patients for depression | 99.2 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 85.7 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 84.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.3 | 96.4 |
News Archive
TeraRecon, Inc. (www.terarecon.com), global leader in advanced visualization and decision support solutions for medical imaging, is highlighting the selection and deployment of its iNtuition™ advanced visualization software by many of North America's largest healthcare enterprises, innovative physician practices and renowned luminary institutions at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago IL.
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 74.9 | 79.6 |
| How often patients got better at getting in and out of bed | 71.8 | 81.1 |
| How often patients got better at bathing | 83.9 | 82.3 |
| How often patients’ breathing improved | 89.4 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 72.6 | 75 |
| How often home health patients had to be admitted to the hospital | 6.6 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.6 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 90.5 | 94 |
News Archive
TeraRecon, Inc. (www.terarecon.com), global leader in advanced visualization and decision support solutions for medical imaging, is highlighting the selection and deployment of its iNtuition™ advanced visualization software by many of North America's largest healthcare enterprises, innovative physician practices and renowned luminary institutions at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago IL.
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
› Verified 6 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
TeraRecon, Inc. (www.terarecon.com), global leader in advanced visualization and decision support solutions for medical imaging, is highlighting the selection and deployment of its iNtuition™ advanced visualization software by many of North America's largest healthcare enterprises, innovative physician practices and renowned luminary institutions at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago IL.
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
› Verified 6 days ago
The patient survey data of Eton Home Healthcare, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 74 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 73 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 59 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 70 | 78 |
News Archive
TeraRecon, Inc. (www.terarecon.com), global leader in advanced visualization and decision support solutions for medical imaging, is highlighting the selection and deployment of its iNtuition™ advanced visualization software by many of North America's largest healthcare enterprises, innovative physician practices and renowned luminary institutions at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place, Chicago IL.
Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.
Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
› Verified 6 days ago
Brookdale Home Health Tulsa Location: 1621 South Eucalyptus Avenue, Broken Arrow, Oklahoma 74012 Ratings: Phone: (918) 298-0275 | |
Angels Care Home Health Of East Oklahoma Location: 751 N Aspen, Broken Arrow, Oklahoma 74012 Ratings: Phone: (918) 251-0952 | |
Allied Home Health Services, Inc Location: 500 North Poplar Ave, Broken Arrow, Oklahoma 74012 Ratings: Phone: (918) 742-4269 | |
Magna Home Health Care, Inc Location: 4271 West Albany, Broken Arrow, Oklahoma 74012 Ratings: Phone: (918) 459-5073 | |
Encompass Health Home Health Of Northeast Oklahoma Location: 1913 West Tacoma Street, Suite G-h, Broken Arrow, Oklahoma 74012 Ratings: Phone: (918) 524-1100 | |
S-q Home Care Specialties, Inc. Location: 2400 North Hemlock Circle, Suite B, Broken Arrow, Oklahoma 74012 Ratings: Phone: (918) 251-0070 |